Wealthcare Advisory Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $659K | Sell |
1,315
-1,391
| -51% | -$668K | 0.01% | 631 |
|
|
2026
Q1 | $1.33M | Buy |
2,706
+299
| +12% | +$162K | 0.03% | 448 |
|
|
2025
Q4 | $1.4M | Buy |
2,407
+61
| +3% | +$34.5K | 0.03% | 434 |
|
|
2025
Q3 | $1.14M | Buy |
2,346
+96
| +4% | +$44.7K | 0.02% | 464 |
|
|
2025
Q2 | $912K | Sell |
2,250
-188
| -8% | -$78.6K | 0.02% | 502 |
|
|
2025
Q1 | $1.21M | Sell |
2,438
-2,668
| -52% | -$1.44M | 0.03% | 404 |
|
|
2024
Q4 | $2.66M | Sell |
5,106
-85
| -2% | -$46.7K | 0.07% | 218 |
|
|
2024
Q3 | $3.21M | Sell |
5,191
-53
| -1% | -$31.4K | 0.09% | 192 |
|
|
2024
Q2 | $2.9M | Sell |
5,244
-90
| -2% | -$51.6K | 0.09% | 181 |
|
|
2024
Q1 | $3.1M | Buy |
5,334
+4,172
| +359% | +$2.34M | 0.1% | 168 |
|
|
2023
Q4 | $617K | Sell |
1,162
-72
| -6% | -$34.9K | 0.02% | 442 |
|
|
2023
Q3 | $624K | Sell |
1,234
-73
| -6% | -$38.9K | 0.03% | 378 |
|
|
2023
Q2 | $682K | Sell |
1,307
-9
| -0.7% | -$4.86K | 0.03% | 376 |
|
|
2023
Q1 | $759K | Buy |
1,316
+59
| +5% | +$33.3K | 0.03% | 354 |
|
|
2022
Q4 | $692K | Buy |
1,257
+179
| +17% | +$94.8K | 0.03% | 344 |
|
|
2022
Q3 | $547K | Buy |
1,078
+295
| +38% | +$165K | 0.03% | 342 |
|
|
2022
Q2 | $426K | Buy |
783
+101
| +15% | +$55.6K | 0.03% | 357 |
|
|
2022
Q1 | $403K | Buy |
682
+26
| +4% | +$14.9K | 0.02% | 350 |
|
|
2021
Q4 | $438K | Buy |
656
+38
| +6% | +$23.7K | 0.03% | 340 |
|
|
2021
Q3 | $353K | Buy |
618
+67
| +12% | +$36.8K | 0.02% | 375 |
|
|
2021
Q2 | $278K | Buy |
551
+22
| +4% | +$10.4K | 0.02% | 441 |
|
|
2021
Q1 | $242K | Buy |
+529
| New | +$252K | 0.02% | 445 |
|
|
2020
Q2 | – | Sell |
-209
| Closed | -$59K | – | 1251 |
|
|
2020
Q1 | $59K | Sell |
209
-44
| -17% | -$13.9K | 0.01% | 478 |
|
|
2019
Q4 | $82K | Sell |
253
-14
| -5% | -$4.25K | 0.01% | 441 |
|
|
2019
Q3 | $78K | Sell |
267
-14
| -5% | -$4.01K | 0.01% | 444 |
|
|
2019
Q2 | $83K | Buy |
281
+14
| +5% | +$3.86K | 0.01% | 418 |
|
|
2019
Q1 | $73K | Buy |
267
+79
| +42% | +$19.7K | 0.01% | 400 |
|
|
2018
Q4 | $42K | Hold |
188
| – | – | 0.01% | 468 |
|
|
2018
Q3 | $46K | Hold |
188
| – | – | 0.01% | 488 |
|
|
2018
Q2 | $39K | Buy |
188
+47
| +33% | +$9.98K | 0.01% | 517 |
|
|
2018
Q1 | $29K | Sell |
141
-97
| -41% | -$20.4K | 0.01% | 518 |
|
|
2017
Q4 | $45K | Buy |
238
+132
| +125% | +$25.3K | 0.01% | 391 |
|
|
2017
Q3 | $20K | Buy |
+106
| New | +$19.2K | 0.01% | 431 |
|
Other funds holding TMO
Wealthcare Advisory Partners's TMO Position: Q2 2026 in Review
Wealthcare Advisory Partners reduced its Thermo Fisher Scientific (TMO) stake by 51% in Q2 2026, selling an estimated $668K and leaving 1,315 shares worth $659K. The position accounts for 0.01% of the portfolio, ranked #631.
Wealthcare Advisory Partners first reported a position in TMO in Q3 2017 and has held it in 33 quarters since. The position peaked at $3.21M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Wealthcare Advisory Partners held 1,315 shares of Thermo Fisher Scientific worth $659K as of Q2 2026.
- Wealthcare Advisory Partners sold 1,391 Thermo Fisher Scientific shares in Q2 2026, an estimated $668K.
- Thermo Fisher Scientific made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #631 holding.
- Wealthcare Advisory Partners first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 33 quarters since.
- Wealthcare Advisory Partners's Thermo Fisher Scientific position peaked at $3.21M in Q3 2024.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.